Industry NewsGammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
Industry NewsThe ongoing COVID-19 outbreaks underscore the importance of SARS-CoV-2 variant detection and tracking
Product NewsSeegene receives CE-IVD mark for use of Combo Swab, a self-collection device with four COVID-19 diagnostic tests
Product NewsInexpensive drug, Fluvoxamine, confirmed as a COVID-19 treatment using Cytel-designed platform trial
Expert InsightsIncreased cellular avidity upon combining multi-targeting and co-stimulation leads to enhanced CAR-T cell sensitivity and persistence
Product NewsNew mass spectrometry portfolio leverages enhanced hardware and software to advance quantitative analysis
Product NewsNext-generation nano-, capillary- and micro-Flow LC systems enhance productivity and performance
